Cardiorenal Protection in Diabetic Kidney Disease
Author:
Funder
University of Toronto
Canadian Institutes of Health Research
Publisher
Korean Endocrine Society
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Link
http://e-enm.org/upload/pdf/enm-2021-987.pdf
Reference106 articles.
1. Sodium Glucose Cotransporter 2 Inhibition Heralds a Call-to-Action for Diabetic Kidney Disease
2. What have we learned about renal protection from the cardiovascular outcome trials and observational analyses with SGLT2 inhibitors?
3. The New Biology of Diabetic Kidney Disease—Mechanisms and Therapeutic Implications
4. Sodium-Glucose Cotransporter-2 Inhibitors in Nephrology Practice: A Narrative Review
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Narrative review investigating the nephroprotective mechanisms of sodium glucose cotransporter type 2 inhibitors in diabetic and nondiabetic patients with chronic kidney disease;Frontiers in Endocrinology;2023-12-20
2. SGLT2 and DPP4 inhibitors improve Alzheimer’s disease–like pathology and cognitive function through distinct mechanisms in a T2D–AD mouse model;Biomedicine & Pharmacotherapy;2023-12
3. Intrarenal Mechanisms of Sodium-Glucose Cotransporter-2 Inhibitors on Tubuloglomerular Feedback and Natriuresis;Endocrinology and Metabolism;2023-08-31
4. Relative and Absolute Risks of Adverse Events with Real-World Use of SGLT2 Inhibitors in CKD;Clinical Journal of the American Society of Nephrology;2023-04-07
5. Renal Protection of Mineralocorticoid Receptor Antagonist, Finerenone, in Diabetic Kidney Disease;Endocrinology and Metabolism;2023-02-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3